首页 > 最新文献

Stroke (Hoboken, N.J.)最新文献

英文 中文
Two‐Piece Craniotomy Is Associated With Improved Postoperative Outcomes of Combined Revascularization in Patients With Moyamoya Disease 两片颅骨切开术与Moyamoya病患者联合血运重建术后疗效的改善相关
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-07 DOI: 10.1161/svin.122.000759
Fumiaki Kanamori, Syuntaro Takasu, N. Hatano, Yoshio Araki, Y. Seki, R. Saito
Revascularization for both anterior cerebral artery (ACA) and middle cerebral artery (MCA) territories in patients with moyamoya disease is often performed in a single operation. The influence of craniotomy type on postoperative outcomes has not been investigated. This study aimed to clarify the effects of craniotomy type on acute postoperative outcomes after combined revascularization by comparing 2‐piece, and large 1‐piece craniotomy approaches. This retrospective study included 337 consecutive combined revascularizations of the ACA and MCA territories in patients with moyamoya disease. Surgeries were classified into 2‐piece and large 1‐piece craniotomy groups. For indirect bypass, the following methods were used: (1) large 1‐piece craniotomy and encephalo‐myo‐galeo‐periosteal‐synangiosis for the MCA and ACA territories; (2) 2‐piece craniotomy and encephalo‐myo‐synangiosis for the MCA territory and encephalo‐periosteal‐synangiosis for the ACA territory. Acute postoperative outcomes were compared between the groups. Two‐piece and large 1‐piece craniotomies were performed in 230 and 107 patients, respectively. The incidence of radiological and symptomatic infarction tended to be lower in the 2‐piece craniotomy group than that in the large 1‐piece craniotomy group (3.9% versus 11.2%; P =0.014, and 2.6% versus 6.5%; P =0.12, respectively). Logistic regression adjusted for potential confounders further explained the relationship between craniotomy type and radiological infarction (large 1‐piece/2‐piece craniotomy: odds ratio, 3.1; 95% CI, 1.2–7.6; P =0.015). In combined revascularization of the ACA and MCA territories in moyamoya disease, 2‐piece craniotomy may reduce the risk of postoperative cerebral infarction.
烟雾病患者大脑前动脉(ACA)和大脑中动脉(MCA)区域的血运重建术通常在一次手术中完成。开颅类型对术后预后的影响尚未研究。本研究旨在通过比较2片开颅术和大1片开颅术,阐明开颅术式对联合血运重建术后急性预后的影响。本回顾性研究包括337例烟雾病患者ACA和MCA区域连续联合血运重建术。手术分为2片开颅组和大1片开颅组。对于间接旁路手术,采用以下方法:(1)大1片开颅术和脑-肌- galeo -骨膜-合并术治疗MCA和ACA区域;(2) 2片开颅术和脑-肌-合并症用于MCA区域,脑-骨膜-合并症用于ACA区域。比较两组急性术后预后。分别对230例和107例患者进行了2片和1片大开颅手术。2片开颅组放射学和症状性梗死的发生率往往低于大1片开颅组(3.9% vs 11.2%;P =0.014, 2.6% vs 6.5%;P =0.12)。经潜在混杂因素调整后的Logistic回归进一步解释了开颅手术类型与影像学梗死之间的关系(大1片/2片开颅术:优势比为3.1;95% ci, 1.2-7.6;P = 0.015)。在烟雾病的ACA和MCA区域联合血运重建术中,2片开颅术可降低术后脑梗死的风险。
{"title":"Two‐Piece Craniotomy Is Associated With Improved Postoperative Outcomes of Combined Revascularization in Patients With Moyamoya Disease","authors":"Fumiaki Kanamori, Syuntaro Takasu, N. Hatano, Yoshio Araki, Y. Seki, R. Saito","doi":"10.1161/svin.122.000759","DOIUrl":"https://doi.org/10.1161/svin.122.000759","url":null,"abstract":"\u0000 \u0000 Revascularization for both anterior cerebral artery (ACA) and middle cerebral artery (MCA) territories in patients with moyamoya disease is often performed in a single operation. The influence of craniotomy type on postoperative outcomes has not been investigated. This study aimed to clarify the effects of craniotomy type on acute postoperative outcomes after combined revascularization by comparing 2‐piece, and large 1‐piece craniotomy approaches.\u0000 \u0000 \u0000 \u0000 This retrospective study included 337 consecutive combined revascularizations of the ACA and MCA territories in patients with moyamoya disease. Surgeries were classified into 2‐piece and large 1‐piece craniotomy groups. For indirect bypass, the following methods were used: (1) large 1‐piece craniotomy and encephalo‐myo‐galeo‐periosteal‐synangiosis for the MCA and ACA territories; (2) 2‐piece craniotomy and encephalo‐myo‐synangiosis for the MCA territory and encephalo‐periosteal‐synangiosis for the ACA territory. Acute postoperative outcomes were compared between the groups.\u0000 \u0000 \u0000 \u0000 \u0000 Two‐piece and large 1‐piece craniotomies were performed in 230 and 107 patients, respectively. The incidence of radiological and symptomatic infarction tended to be lower in the 2‐piece craniotomy group than that in the large 1‐piece craniotomy group (3.9% versus 11.2%;\u0000 P\u0000 =0.014, and 2.6% versus 6.5%;\u0000 P\u0000 =0.12, respectively). Logistic regression adjusted for potential confounders further explained the relationship between craniotomy type and radiological infarction (large 1‐piece/2‐piece craniotomy: odds ratio, 3.1; 95% CI, 1.2–7.6;\u0000 P\u0000 =0.015).\u0000 \u0000 \u0000 \u0000 \u0000 In combined revascularization of the ACA and MCA territories in moyamoya disease, 2‐piece craniotomy may reduce the risk of postoperative cerebral infarction.\u0000","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46822693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraarterial Transplantation of Mitochondria After Ischemic Stroke Reduces Cerebral Infarction. 缺血性脑卒中后的线粒体动脉内移植可减少脑梗塞。
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-01 Epub Date: 2023-03-02 DOI: 10.1161/svin.122.000644
Pedro Norat, Jennifer D Sokolowski, Catherine M Gorick, Sauson Soldozy, Jeyan S Kumar, Youngrok Chae, Kaan Yagmurlu, Joelle Nilak, Khadijeh A Sharifi, Melanie Walker, Michael R Levitt, Alexander L Klibanov, Zhen Yan, Richard J Price, Petr Tvrdik, M Yashar S Kalani

Background-: Transplantation of autologous mitochondria into ischemic tissue may mitigate injury caused by ischemia and reperfusion.

Methods-: Using murine stroke models of middle cerebral artery occlusion, we sought to evaluate feasibility of delivery of viable mitochondria to ischemic brain parenchyma. We evaluated the effects of concurrent focused ultrasound activation of microbubbles, which serves to open the blood-brain barrier, on efficacy of delivery of mitochondria.

Results-: Following intra-arterial delivery, mitochondria distribute through the stroked hemisphere and integrate into neural and glial cells in the brain parenchyma. Consistent with functional integration in the ischemic tissue, the transplanted mitochondria elevate concentration of adenosine triphosphate in the stroked hemisphere, reduce infarct volume and increase cell viability. Additional of focused ultrasound leads to improved blood brain barrier opening without hemorrhagic complications.

Conclusions-: Our results have implications for the development of interventional strategies after ischemic stroke and suggest a novel potential modality of therapy after mechanical thrombectomy.

背景将自体线粒体移植到缺血组织可减轻缺血和再灌注造成的损伤:我们利用大脑中动脉闭塞的小鼠中风模型,试图评估向缺血脑实质输送存活线粒体的可行性。我们评估了同时用聚焦超声激活微气泡(微气泡的作用是打开血脑屏障)对线粒体输送效果的影响:结果:动脉内递送线粒体后,线粒体分布于中风半球,并融入脑实质中的神经细胞和胶质细胞。与缺血组织中的功能整合相一致,移植的线粒体提高了中风半球中三磷酸腺苷的浓度,缩小了梗死体积,并增加了细胞活力。额外的聚焦超声改善了血脑屏障的开放,但没有出血并发症:我们的研究结果对缺血性中风后介入治疗策略的发展具有重要意义,并为机械性血栓切除术后的治疗提供了一种新的潜在模式。
{"title":"Intraarterial Transplantation of Mitochondria After Ischemic Stroke Reduces Cerebral Infarction.","authors":"Pedro Norat, Jennifer D Sokolowski, Catherine M Gorick, Sauson Soldozy, Jeyan S Kumar, Youngrok Chae, Kaan Yagmurlu, Joelle Nilak, Khadijeh A Sharifi, Melanie Walker, Michael R Levitt, Alexander L Klibanov, Zhen Yan, Richard J Price, Petr Tvrdik, M Yashar S Kalani","doi":"10.1161/svin.122.000644","DOIUrl":"10.1161/svin.122.000644","url":null,"abstract":"<p><strong>Background-: </strong>Transplantation of autologous mitochondria into ischemic tissue may mitigate injury caused by ischemia and reperfusion.</p><p><strong>Methods-: </strong>Using murine stroke models of middle cerebral artery occlusion, we sought to evaluate feasibility of delivery of viable mitochondria to ischemic brain parenchyma. We evaluated the effects of concurrent focused ultrasound activation of microbubbles, which serves to open the blood-brain barrier, on efficacy of delivery of mitochondria.</p><p><strong>Results-: </strong>Following intra-arterial delivery, mitochondria distribute through the stroked hemisphere and integrate into neural and glial cells in the brain parenchyma. Consistent with functional integration in the ischemic tissue, the transplanted mitochondria elevate concentration of adenosine triphosphate in the stroked hemisphere, reduce infarct volume and increase cell viability. Additional of focused ultrasound leads to improved blood brain barrier opening without hemorrhagic complications.</p><p><strong>Conclusions-: </strong>Our results have implications for the development of interventional strategies after ischemic stroke and suggest a novel potential modality of therapy after mechanical thrombectomy.</p>","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":"3 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9950485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Man vs Machine: Predicting First‐Pass Recanalization After Endovascular Thrombectomy 人与机器:预测血管内血栓切除术后的首次再分析
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-01 DOI: 10.1161/svin.123.000836
A. Garg, E. Samaniego
{"title":"Man vs Machine: Predicting First‐Pass Recanalization After Endovascular Thrombectomy","authors":"A. Garg, E. Samaniego","doi":"10.1161/svin.123.000836","DOIUrl":"https://doi.org/10.1161/svin.123.000836","url":null,"abstract":"","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43151670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thrombectomy in Patients With Active Malignancy 活动性恶性肿瘤患者的血栓切除术
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-01 DOI: 10.1161/svin.123.000835
J. Siegler, Thanh N. Nguyen
{"title":"Thrombectomy in Patients With Active Malignancy","authors":"J. Siegler, Thanh N. Nguyen","doi":"10.1161/svin.123.000835","DOIUrl":"https://doi.org/10.1161/svin.123.000835","url":null,"abstract":"","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44464838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissection Dilemma: Risk Stratification and Antithrombotic Selection 解剖困境:风险分层与抗血栓选择
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-01 DOI: 10.1161/svin.123.000841
Mary Penckofer, J. Siegler
{"title":"Dissection Dilemma: Risk Stratification and Antithrombotic Selection","authors":"Mary Penckofer, J. Siegler","doi":"10.1161/svin.123.000841","DOIUrl":"https://doi.org/10.1161/svin.123.000841","url":null,"abstract":"","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48150194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the Cover Submission 关于提交封面
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-01 DOI: 10.1161/svin.122.000691
S. Sanchez
{"title":"On the Cover Submission","authors":"S. Sanchez","doi":"10.1161/svin.122.000691","DOIUrl":"https://doi.org/10.1161/svin.122.000691","url":null,"abstract":"","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64515641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of 90‐Day Home Time Among Patients With Medium‐Vessel Occlusion Undergoing Endovascular Thrombectomy 血管内血栓切除术中血管闭塞患者90天回家时间的预测
Q3 CLINICAL NEUROLOGY Pub Date : 2023-05-01 DOI: 10.1161/svin.122.000748
N. Singh, F. Bala, N. Kashani, M. Horn, J. Stang, A. Demchuk, Michael D. Hill, M. Almekhlafi, J. Holodinsky
The benefit of endovascular thrombectomy for medium‐vessel occlusion (MeVO) strokes is unclear. We used 90‐day home time to explore outcomes in patients with MeVO versus large‐vessel occlusions treated with endovascular thrombectomy. Data are from the QuICR (Quality Improvement and Clinical Research) provincial stroke registry and linked administrative data to identify patients who underwent endovascular thrombectomy in our center from January 2015 to December 2020. Imaging data were scored by 2‐physician consensus. We defined MeVO as occlusion beyond and including M2–middle cerebral artery, A2–anterior cerebral artery, or P2–posterior cerebral artery segments. Successful reperfusion was defined as Thrombolysis in Cerebral ischemia grades (≥2b/3). The primary outcome was patient home time (the number of nights a patient is back at their premorbid living situation without an increase in level of care within 90 days of the stroke) using random forest regression. Covariate contribution to home time was determined using partial dependence plots. Among 663 patients who underwent endovascular thrombectomy, 139 (20.9%) had MeVO (median age, 71 years; 50.4% women; median National Institutes of Health Stroke Scale, 16). The majority (82%) had good pial collaterals, 10.4% had a tandem extracranial carotid occlusion or stenosis, and 41.7% received intravenous thrombolysis. The most common site of occlusion was M2–middle cerebral artery (58.3%). One hundred eighteen (86.7%) patients achieved successful reperfusion (Thrombolysis in Cerebral Ischemia grades ≥2b/3). Using partial dependence plots, the mean predicted home times were similar in patients with MeVO (45.5 days) versus large‐vessel occlusions (44.6 days). Factors predicting lower 90‐day home time in patients with MeVOs were diabetes (−8.7 days), hypertension (−6.5 days), and atrial fibrillation (−3.5 days). There was no meaningful difference in predicted 90‐day home‐time by sex, baseline National Institutes of Health Stroke Scale, collateral grade, or thrombolysis. Patients with MeVO who are selected for endovascular therapy with similar demographic and clinical profiles to large‐vessel occlusions can achieve similar 90‐day home time outcomes to large‐vessel occlusions.
血管内血栓切除术对中血管闭塞(MeVO)卒中的益处尚不清楚。我们使用90天的居家时间来探讨MeVO患者与血管内血栓切除术治疗大血管闭塞患者的疗效。数据来自QuICR(质量改进和临床研究)省级中风登记处,并关联管理数据,以确定2015年1月至2020年12月在我中心接受血管内血栓切除术的患者。影像学数据由两位医师一致评分。我们将MeVO定义为超过并包括M2–大脑中动脉、A2–大脑前动脉或P2–大脑后动脉段的闭塞。再灌注成功被定义为脑缺血级别(≥2b/3)的血栓溶解。主要结果是使用随机森林回归的患者回家时间(患者在中风后90天内恢复到病前生活状态而护理水平没有提高的夜晚数)。使用部分依赖图确定了对回家时间的协变量贡献。在663名接受血管内血栓切除术的患者中,139名(20.9%)患有MeVO(中位年龄71岁;50.4%为女性;中位美国国立卫生研究院卒中量表,16)。大多数患者(82%)有良好的软脑膜侧支,10.4%有串联的颅外颈动脉闭塞或狭窄,41.7%接受了静脉溶栓治疗。最常见的闭塞部位是大脑中动脉M2(58.3%)。118例(86.7%)患者成功再灌注(脑缺血溶栓分级≥2b/3)。使用部分依赖图,MeVO患者的平均预测回家时间(45.5天)与大血管闭塞患者的平均预计回家时间(44.6天)相似。预测MeVOs患者90天居家时间较低的因素是糖尿病(−8.7天)、高血压(−6.5天)和心房颤动(−3.5天)。按性别、美国国立卫生研究院基线卒中量表、侧支循环分级或溶栓治疗,预测的90天回家时间没有显著差异。选择与大血管闭塞具有相似人口统计学和临床特征的MeVO患者进行血管内治疗,可以获得与大血管阻塞相似的90天居家时间结果。
{"title":"Prediction of 90‐Day Home Time Among Patients With Medium‐Vessel Occlusion Undergoing Endovascular Thrombectomy","authors":"N. Singh, F. Bala, N. Kashani, M. Horn, J. Stang, A. Demchuk, Michael D. Hill, M. Almekhlafi, J. Holodinsky","doi":"10.1161/svin.122.000748","DOIUrl":"https://doi.org/10.1161/svin.122.000748","url":null,"abstract":"\u0000 \u0000 The benefit of endovascular thrombectomy for medium‐vessel occlusion (MeVO) strokes is unclear. We used 90‐day home time to explore outcomes in patients with MeVO versus large‐vessel occlusions treated with endovascular thrombectomy.\u0000 \u0000 \u0000 \u0000 Data are from the QuICR (Quality Improvement and Clinical Research) provincial stroke registry and linked administrative data to identify patients who underwent endovascular thrombectomy in our center from January 2015 to December 2020. Imaging data were scored by 2‐physician consensus. We defined MeVO as occlusion beyond and including M2–middle cerebral artery, A2–anterior cerebral artery, or P2–posterior cerebral artery segments. Successful reperfusion was defined as Thrombolysis in Cerebral ischemia grades (≥2b/3). The primary outcome was patient home time (the number of nights a patient is back at their premorbid living situation without an increase in level of care within 90 days of the stroke) using random forest regression. Covariate contribution to home time was determined using partial dependence plots.\u0000 \u0000 \u0000 \u0000 Among 663 patients who underwent endovascular thrombectomy, 139 (20.9%) had MeVO (median age, 71 years; 50.4% women; median National Institutes of Health Stroke Scale, 16). The majority (82%) had good pial collaterals, 10.4% had a tandem extracranial carotid occlusion or stenosis, and 41.7% received intravenous thrombolysis. The most common site of occlusion was M2–middle cerebral artery (58.3%). One hundred eighteen (86.7%) patients achieved successful reperfusion (Thrombolysis in Cerebral Ischemia grades ≥2b/3). Using partial dependence plots, the mean predicted home times were similar in patients with MeVO (45.5 days) versus large‐vessel occlusions (44.6 days). Factors predicting lower 90‐day home time in patients with MeVOs were diabetes (−8.7 days), hypertension (−6.5 days), and atrial fibrillation (−3.5 days). There was no meaningful difference in predicted 90‐day home‐time by sex, baseline National Institutes of Health Stroke Scale, collateral grade, or thrombolysis.\u0000 \u0000 \u0000 \u0000 Patients with MeVO who are selected for endovascular therapy with similar demographic and clinical profiles to large‐vessel occlusions can achieve similar 90‐day home time outcomes to large‐vessel occlusions.\u0000","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47739786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular Thrombectomy Versus Best Medical Management Beyond 24 Hours From Last Known Well in Acute Ischemic Stroke Due to Large Vessel Occlusion 血管内血栓切除术与大血管闭塞引起的急性缺血性卒中24小时后的最佳医疗管理
Q3 CLINICAL NEUROLOGY Pub Date : 2023-04-28 DOI: 10.1161/svin.122.000790
P. Dhillon, Waleed Z. Butt, T. Jovin, A. Podlasek, N. McConachie, R. Lenthall, S. Nair, Luqman Malik, K. Krishnan, R. Dineen, T. England
The safety and efficacy of endovascular thrombectomy (EVT) in patients with acute ischemic stroke due to large vessel occlusion presenting beyond 24 hours from last known well (LKW) remains undetermined. In this single center study, we identified patients with large vessel occlusion who were eligible for EVT based on noncontrast computed tomography (CT)/CT angiography (without CT perfusion or magnetic resonance imaging) using an Alberta Stroke Program Early CT Score of ≥5, National Institutes of Health Stroke Scale of ≥6, and presenting beyond 24 hours from LKW, between January 2018 and March 2022. During the study period, EVT service limitations meant patients eligible for EVT presenting outside service hours, routinely received best medical management (BMM). Functional and safety outcomes were compared between patients receiving EVT or BMM following multivariable adjustment for age, baseline stroke severity, Alberta Stroke Program Early CT Score, time from LKW, IV thrombolysis, and clot location. Among 35 patients presenting beyond 24 hours from LKW and eligible for EVT, 19 (54%) were treated with EVT and 16 (46%) with BMM. Alberta Stroke Program Early CT Score were similar across both groups (EVT: 7 [6.75–8] versus BMM: 7 [6–8]), but not the baseline National Institutes of Health Stroke Scale (EVT: 17 [11–19.5] versus BMM: 20 [9.75–26]). No significant difference was observed between the EVT and BMM groups in the symptomatic intracranial hemorrhage (5.3% versus 0%; P =0.28) or mortality (26.3% versus 37.5%; P =0.42) rates, respectively. The modified Rankin scale at 90 days (adjusted common odds ratio [OR], 1.94; [95% CI 0.42–8.87]; P =0.39) and functional independence rate, although numerically higher in the EVT group compared with the BMM group (modified Rankin scale≤2; 36.9% versus 18.8%; adjusted OR, 4.34; [95% CI 0.34–54.83]; P =0.25), were not significantly different. 94.7% of patients treated with EVT achieved successful reperfusion (modified thrombolysis in cerebral infarction 2b–3). In routine clinical practice, EVT beyond 24 hours from LKW appears safe and feasible, when performed in patients with acute ischemic stroke who were deemed eligible for EVT by noncontrast CT /CT angiography alone. A large collaborative randomized trial assessing the efficacy of EVT beyond 24 hours is warranted. Our findings provide a basis for the sample size estimate for an adequately powered trial.
血管内血栓切除术(EVT)治疗因大血管闭塞导致的急性缺血性卒中患者的安全性和有效性尚不确定。在这项单中心研究中,我们根据阿尔伯塔省卒中项目早期CT评分≥5,美国国立卫生研究院卒中量表≥6,并在LKW后24小时内出现的非扫描计算机断层扫描(CT)/CT血管造影术(无CT灌注或磁共振成像),确定了符合EVT条件的大血管闭塞患者,2018年1月至2022年3月。在研究期间,EVT服务限制意味着有资格在服务时间外接受EVT的患者通常接受最佳医疗管理(BMM)。在对年龄、基线卒中严重程度、艾伯塔省卒中项目早期CT评分、LKW时间、静脉溶栓和血栓位置进行多变量调整后,比较接受EVT或BMM的患者的功能和安全性结果。在35名从LKW出现超过24小时并符合EVT条件的患者中,19名(54%)接受了EVT治疗,16名(46%)接受了BMM治疗。阿尔伯塔省卒中项目早期CT评分在两组中相似(EVT:7[6.75-8]与BMM:7[6-8]),但不是美国国立卫生研究院的基线卒中量表(EVT:17[11-19.5]与BMM:20[9.75-26])。EVT和BMM组在症状性颅内出血率(5.3%与0%;P=0.28)或死亡率(26.3%与37.5%;P=0.42)方面没有观察到显著差异。90天时的改良Rankin量表(调整后的共同优势比[OR],1.94;[95%CI 0.42–8.87];P=0.39)和功能独立率,尽管EVT组在数字上高于BMM组(改良Rankin表≤2;36.9%对18.8%;调整后的OR,4.34;[95%CI 0.34–54.83];P=0.25),没有显著差异。94.7%接受EVT治疗的患者成功再灌注(改良脑梗死溶栓2b–3)。在常规临床实践中,当对急性缺血性卒中患者进行EVT时,从LKW开始超过24小时的EVT似乎是安全可行的,这些患者被认为有资格单独通过非扫描CT/CT血管造影术进行EVT。有必要进行一项大型随机合作试验,评估EVT在24小时后的疗效。我们的发现为充分有力的试验的样本量估计提供了基础。
{"title":"Endovascular Thrombectomy Versus Best Medical Management Beyond 24 Hours From Last Known Well in Acute Ischemic Stroke Due to Large Vessel Occlusion","authors":"P. Dhillon, Waleed Z. Butt, T. Jovin, A. Podlasek, N. McConachie, R. Lenthall, S. Nair, Luqman Malik, K. Krishnan, R. Dineen, T. England","doi":"10.1161/svin.122.000790","DOIUrl":"https://doi.org/10.1161/svin.122.000790","url":null,"abstract":"\u0000 \u0000 The safety and efficacy of endovascular thrombectomy (EVT) in patients with acute ischemic stroke due to large vessel occlusion presenting beyond 24 hours from last known well (LKW) remains undetermined.\u0000 \u0000 \u0000 \u0000 In this single center study, we identified patients with large vessel occlusion who were eligible for EVT based on noncontrast computed tomography (CT)/CT angiography (without CT perfusion or magnetic resonance imaging) using an Alberta Stroke Program Early CT Score of ≥5, National Institutes of Health Stroke Scale of ≥6, and presenting beyond 24 hours from LKW, between January 2018 and March 2022. During the study period, EVT service limitations meant patients eligible for EVT presenting outside service hours, routinely received best medical management (BMM). Functional and safety outcomes were compared between patients receiving EVT or BMM following multivariable adjustment for age, baseline stroke severity, Alberta Stroke Program Early CT Score, time from LKW, IV thrombolysis, and clot location.\u0000 \u0000 \u0000 \u0000 \u0000 Among 35 patients presenting beyond 24 hours from LKW and eligible for EVT, 19 (54%) were treated with EVT and 16 (46%) with BMM. Alberta Stroke Program Early CT Score were similar across both groups (EVT: 7 [6.75–8] versus BMM: 7 [6–8]), but not the baseline National Institutes of Health Stroke Scale (EVT: 17 [11–19.5] versus BMM: 20 [9.75–26]). No significant difference was observed between the EVT and BMM groups in the symptomatic intracranial hemorrhage (5.3% versus 0%;\u0000 P\u0000 =0.28) or mortality (26.3% versus 37.5%;\u0000 P\u0000 =0.42) rates, respectively. The modified Rankin scale at 90 days (adjusted common odds ratio [OR], 1.94; [95% CI 0.42–8.87];\u0000 P\u0000 =0.39) and functional independence rate, although numerically higher in the EVT group compared with the BMM group (modified Rankin scale≤2; 36.9% versus 18.8%; adjusted OR, 4.34; [95% CI 0.34–54.83];\u0000 P\u0000 =0.25), were not significantly different. 94.7% of patients treated with EVT achieved successful reperfusion (modified thrombolysis in cerebral infarction 2b–3).\u0000 \u0000 \u0000 \u0000 \u0000 In routine clinical practice, EVT beyond 24 hours from LKW appears safe and feasible, when performed in patients with acute ischemic stroke who were deemed eligible for EVT by noncontrast CT /CT angiography alone. A large collaborative randomized trial assessing the efficacy of EVT beyond 24 hours is warranted. Our findings provide a basis for the sample size estimate for an adequately powered trial.\u0000","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47043498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of Workflow Improvements on Time to Endovascular Thrombectomy for Acute Ischemic Stroke in the MR CLEAN Registry MR CLEAN注册表中工作流程改进对急性缺血性卒中血管内血栓切除时间的影响
Q3 CLINICAL NEUROLOGY Pub Date : 2023-04-27 DOI: 10.1161/svin.122.000733
P. M. Janssen, B. Roozenbeek, J. Coutinho, A. V. van Es, W. Schonewille, G. Lycklama à Nijeholt, Hester F. Lingsma, D. Dippel
Insight in the effect of workflow improvements can help to minimize the time between onset of ischemic stroke and start of endovascular thrombectomy (EVT). The authors aimed to assess the implementation of EVT workflow strategies and their effect on time to treatment. The authors used data from the MR CLEAN (Multicenter Randomized Controlled Trial of Endovascular Treatment for Acute Ischemic Stroke in The Netherlands) registry and included patients with acute ischemic stroke in the anterior circulation, who underwent EVT between March 2014 and November 2017. Data on implementation of 20 predefined workflow improvement strategies during the study period were collected from each intervention center. Multilevel linear regression with a random intercept for center was used to quantify the effect of each strategy on door‐to‐groin puncture time, with adjustment for calendar time, for directly presented and transferred patients separately. The authors included 2633 patients who were treated in 14 intervention centers. Of the 20 predefined strategies, 18 were actually implemented in ≥1 centers during the study period. In directly presented patients (n=1157), the intervention with the largest effect on door‐to‐groin puncture time was a strategy to avoid sedation during EVT compared with standard use of general anesthesia, which led to a reduction of 29% (95% CI, 6–46; P =0.02), corresponding to a decrease of 26 minutes (95% CI, 5–42). In transferred patients (n=1476), the interventions with the largest decrease in door‐to‐groin puncture time were a strategy to make the decision for patient transfer to the angiosuite after 1 stroke physician assessed the imaging, instead of both interventionist and neurologist (47% [95% CI, 5–70]; 19 minutes [95% CI, 2–29]) ( P =0.03), and a strategy to perform neurological assessment at the angiosuite instead of the emergency department (32% [95% CI, 19–43]; 13 minutes [95% CI, 8–17]) ( P <0.001). Intervention centers have implemented multiple new strategies to improve their workflow. Such workflow improvements lead to substantial reductions in time to EVT and may thereby improve the outcome of patients with acute ischemic stroke.
了解工作流程改进的效果可以帮助缩短缺血性卒中发作和血管内血栓切除术(EVT)开始之间的时间。作者旨在评估EVT工作流程策略的实施及其对治疗时间的影响。作者使用了MR CLEAN(荷兰急性缺血性卒中血管内治疗多中心随机对照试验)登记的数据,并纳入了2014年3月至2017年11月期间接受EVT的前循环急性缺血性卒中患者。在研究期间,从每个干预中心收集20个预定义的工作流程改进策略的实施数据。采用以随机截距为中心的多水平线性回归,分别对直接就诊和转诊的患者,在日历时间的调整下,量化每种策略对门-腹股沟穿刺时间的影响。作者纳入了在14个干预中心接受治疗的2633名患者。在20个预定义的策略中,18个在研究期间在≥1个中心实际实施。在直接就诊的患者中(n=1157),与标准使用全身麻醉相比,对门至腹股沟穿刺时间影响最大的干预措施是在EVT期间避免镇静,可减少29% (95% CI, 6-46;P =0.02),相当于减少了26分钟(95% CI, 5-42)。在转院患者(n=1476)中,减少门静脉到腹股沟穿刺时间最多的干预措施是在一名卒中医生评估成像后,而不是在介入医生和神经科医生共同评估成像后,决定患者转到血管套房的策略(47% [95% CI, 5-70];19分钟[95% CI, 2-29]) (P =0.03),以及在血管套房而不是急诊科进行神经学评估的策略(32% [95% CI, 19 - 43];13分钟[95% CI, 8-17]) (P <0.001)。干预中心已经实施了多种新的策略来改善他们的工作流程。这种工作流程的改进导致EVT时间的大幅减少,从而可能改善急性缺血性卒中患者的预后。
{"title":"Effect of Workflow Improvements on Time to Endovascular Thrombectomy for Acute Ischemic Stroke in the MR CLEAN Registry","authors":"P. M. Janssen, B. Roozenbeek, J. Coutinho, A. V. van Es, W. Schonewille, G. Lycklama à Nijeholt, Hester F. Lingsma, D. Dippel","doi":"10.1161/svin.122.000733","DOIUrl":"https://doi.org/10.1161/svin.122.000733","url":null,"abstract":"\u0000 \u0000 Insight in the effect of workflow improvements can help to minimize the time between onset of ischemic stroke and start of endovascular thrombectomy (EVT). The authors aimed to assess the implementation of EVT workflow strategies and their effect on time to treatment.\u0000 \u0000 \u0000 \u0000 The authors used data from the MR CLEAN (Multicenter Randomized Controlled Trial of Endovascular Treatment for Acute Ischemic Stroke in The Netherlands) registry and included patients with acute ischemic stroke in the anterior circulation, who underwent EVT between March 2014 and November 2017. Data on implementation of 20 predefined workflow improvement strategies during the study period were collected from each intervention center. Multilevel linear regression with a random intercept for center was used to quantify the effect of each strategy on door‐to‐groin puncture time, with adjustment for calendar time, for directly presented and transferred patients separately.\u0000 \u0000 \u0000 \u0000 \u0000 The authors included 2633 patients who were treated in 14 intervention centers. Of the 20 predefined strategies, 18 were actually implemented in ≥1 centers during the study period. In directly presented patients (n=1157), the intervention with the largest effect on door‐to‐groin puncture time was a strategy to avoid sedation during EVT compared with standard use of general anesthesia, which led to a reduction of 29% (95% CI, 6–46;\u0000 P\u0000 =0.02), corresponding to a decrease of 26 minutes (95% CI, 5–42). In transferred patients (n=1476), the interventions with the largest decrease in door‐to‐groin puncture time were a strategy to make the decision for patient transfer to the angiosuite after 1 stroke physician assessed the imaging, instead of both interventionist and neurologist (47% [95% CI, 5–70]; 19 minutes [95% CI, 2–29]) (\u0000 P\u0000 =0.03), and a strategy to perform neurological assessment at the angiosuite instead of the emergency department (32% [95% CI, 19–43]; 13 minutes [95% CI, 8–17]) (\u0000 P\u0000 <0.001).\u0000 \u0000 \u0000 \u0000 \u0000 Intervention centers have implemented multiple new strategies to improve their workflow. Such workflow improvements lead to substantial reductions in time to EVT and may thereby improve the outcome of patients with acute ischemic stroke.\u0000","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44274398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison Between In‐Hospital and Community‐Onset Stroke Treated With Endovascular Thrombectomy: A Propensity Score–Matched Cohort Study 一项倾向评分匹配的队列研究:医院内和社区内血管内血栓切除术治疗卒中的比较
Q3 CLINICAL NEUROLOGY Pub Date : 2023-04-25 DOI: 10.1161/svin.122.000816
P. Dhillon, Emma Soo, Waleed Z. Butt, Thanh N. Nguyen, E. Barrett, A. Podlasek, N. McConachie, R. Lenthall, S. Nair, Luqman Malik, Chesvin Cheema, P. Bhogal, H. Makalanda, M. James, R. Dineen, T. England
Patients with acute ischemic stroke onset during hospital admission often have concurrent illnesses, increased underlying comorbidities and are often associated with a delayed recognition of stroke onset, compared with patients with stroke onset in the community (community‐onset stroke [COS]). Endovascular thrombectomy (EVT) for large‐vessel occlusion in acute ischemic stroke has been proven to be effective, though the safety and feasibility of EVT among patients with in‐hospital stroke (IHS) onset remains undetermined. We aim to compare the workflow and clinical outcomes for patients undergoing EVT following IHS onset and COS. Using data from a national stroke registry, we used propensity score‐matched individual‐level data of patients who underwent EVT, following IHS and COS, between October 2015 and March 2020. Univariate analysis was performed to assess the procedural, functional, and safety outcomes. We included 4353 patients (COS, 4104 [249 after propensity score matching]; IHS, 249 [249 after propensity score matching]). Compared with COS, patients with IHS had similar modified Rankin Scale on discharge (odds ratio [OR], 0.98 [95% CI, 0.72–1.34]; P =0.96) and at 6 months (OR, 1.25 [95% CI, 0.71–2.24]; P =0.48). No significant difference in achieving good functional outcome (modified Rankin Scale ≤ 2 at discharge; 31.3% [IHS] versus 29.3% [COS]; OR,=1.10 [95% CI 0.74–1.60]; P =0.61), successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b–3), P =0.82; or safety outcomes of symptomatic intracranial hemorrhage ( P =0.64) and in‐hospital mortality ( P =0.26) were demonstrated. Shorter time interval from stroke onset to imaging in the IHS group (IHS, 80±88 versus COS, 216±292 minutes) was observed. The imaging‐to‐arterial‐puncture time was not significantly different between the groups (IHS, 160±140 versus COS, 162±184 minutes; P =0.85). EVT in patients with IHS is safe and feasible, with comparable functional and safety outcomes to patients with COS, in this national stroke registry. Continued efforts are required to improve the inpatient stroke workflow in recognizing stroke symptoms and initiating reperfusion treatment for eligible patients with IHS.
与社区脑卒中患者相比,住院期间急性缺血性脑卒中患者通常并发疾病,潜在合并症增加,并且通常与对脑卒中发作的延迟识别有关(社区脑卒中[COS])。血管内血栓切除术(EVT)治疗急性缺血性卒中大血管闭塞已被证明是有效的,尽管EVT在院内卒中(IHS)患者中的安全性和可行性尚不确定。我们的目的是比较IHS发作和COS后接受EVT的患者的工作流程和临床结果。使用国家中风登记处的数据,我们使用了2015年10月至2020年3月期间接受EVT、IHS和COS的患者的倾向得分匹配的个人水平数据。进行单变量分析以评估手术、功能和安全性结果。我们纳入了4353名患者(COS,4104[249倾向评分匹配后];IHS,249倾向评分匹配前])。与COS相比,IHS患者出院时的改良Rankin量表(比值比[OR],0.98[95%CI,0.72-1.34];P=0.96)和6个月时的改良兰金量表(OR,1.25[95%CI;0.71-2.24];P=0.48)相似。在获得良好的功能结果方面没有显著差异(出院时改良Rankin量表≤2;31.3%[IHS]与29.3%[COS];OR,=1.10[95%CI 0.74-1.60];P=0.61),再灌注成功(改良的脑梗死溶栓评分为2b–3),P=0.82;或症状性颅内出血(P=0.64)和住院死亡率(P=0.26)的安全性结果。IHS组从中风发作到成像的时间间隔更短(IHS为80±88分钟,COS为216±292分钟)。两组之间的成像到动脉穿刺时间没有显著差异(IHS,160±140与COS,162±184分钟;P=0.85)。在国家中风登记中,IHS患者的EVT是安全可行的,其功能和安全性结果与COS患者相当。需要继续努力改善住院中风工作流程,以识别中风症状并启动符合条件的IHS患者的再灌注治疗。
{"title":"Comparison Between In‐Hospital and Community‐Onset Stroke Treated With Endovascular Thrombectomy: A Propensity Score–Matched Cohort Study","authors":"P. Dhillon, Emma Soo, Waleed Z. Butt, Thanh N. Nguyen, E. Barrett, A. Podlasek, N. McConachie, R. Lenthall, S. Nair, Luqman Malik, Chesvin Cheema, P. Bhogal, H. Makalanda, M. James, R. Dineen, T. England","doi":"10.1161/svin.122.000816","DOIUrl":"https://doi.org/10.1161/svin.122.000816","url":null,"abstract":"\u0000 \u0000 Patients with acute ischemic stroke onset during hospital admission often have concurrent illnesses, increased underlying comorbidities and are often associated with a delayed recognition of stroke onset, compared with patients with stroke onset in the community (community‐onset stroke [COS]). Endovascular thrombectomy (EVT) for large‐vessel occlusion in acute ischemic stroke has been proven to be effective, though the safety and feasibility of EVT among patients with in‐hospital stroke (IHS) onset remains undetermined. We aim to compare the workflow and clinical outcomes for patients undergoing EVT following IHS onset and COS.\u0000 \u0000 \u0000 \u0000 Using data from a national stroke registry, we used propensity score‐matched individual‐level data of patients who underwent EVT, following IHS and COS, between October 2015 and March 2020. Univariate analysis was performed to assess the procedural, functional, and safety outcomes.\u0000 \u0000 \u0000 \u0000 \u0000 We included 4353 patients (COS, 4104 [249 after propensity score matching]; IHS, 249 [249 after propensity score matching]). Compared with COS, patients with IHS had similar modified Rankin Scale on discharge (odds ratio [OR], 0.98 [95% CI, 0.72–1.34];\u0000 P\u0000 =0.96) and at 6 months (OR, 1.25 [95% CI, 0.71–2.24];\u0000 P\u0000 =0.48). No significant difference in achieving good functional outcome (modified Rankin Scale ≤ 2 at discharge; 31.3% [IHS] versus 29.3% [COS]; OR,=1.10 [95% CI 0.74–1.60];\u0000 P\u0000 =0.61), successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b–3),\u0000 P\u0000 =0.82; or safety outcomes of symptomatic intracranial hemorrhage (\u0000 P\u0000 =0.64) and in‐hospital mortality (\u0000 P\u0000 =0.26) were demonstrated. Shorter time interval from stroke onset to imaging in the IHS group (IHS, 80±88 versus COS, 216±292 minutes) was observed. The imaging‐to‐arterial‐puncture time was not significantly different between the groups (IHS, 160±140 versus COS, 162±184 minutes;\u0000 P\u0000 =0.85).\u0000 \u0000 \u0000 \u0000 \u0000 EVT in patients with IHS is safe and feasible, with comparable functional and safety outcomes to patients with COS, in this national stroke registry. Continued efforts are required to improve the inpatient stroke workflow in recognizing stroke symptoms and initiating reperfusion treatment for eligible patients with IHS.\u0000","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48119778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Stroke (Hoboken, N.J.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1